Chevallard Daniel R. 4
4 · LENZ Therapeutics, Inc. · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Chevallard Daniel R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-11-07$22.71/sh+20$454→ 3,208 total - Purchase
Common Stock
2025-11-07$22.76/sh+2,178$49,563→ 5,386 total